MicroRNA-2055b inhibits HMGB1 expression in LPS-induced sepsis

International Journal of Molecular Medicine

Volumn 38, Issue 1, 2016, Pages 312-318

  Zhou, Wenhai ^a   Wang, Jing ^a   Li, Zhifeng ^a   Li, Jianguo ^a   Sang, Ming ^b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Cholinergic anti inflammatory pathway; High mobility group box 1; MicroRNA 2055b; Sepsis

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; MICRORNA 205; MICRORNA 205 5B; UNCLASSIFIED DRUG; 3-(2,4-DIMETHOXYBENZYLIDENE)ANABASEINE; BENZYLIDENE DERIVATIVE; MICRORNA; MIRN205 MICRORNA, MOUSE; PYRIDINE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC SCREENING; LIVER; LUNG; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROCESSING; PROTEIN RNA BINDING; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEPSIS; SPLEEN; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; RAW 264.7 CELL LINE;

ANIMALS; BENZYLIDENE COMPOUNDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PYRIDINES; RAW 264.7 CELLS; SEPSIS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84978877512     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2613     Document Type: Article

References (29)

1. Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, et al: HMGB1 in health and disease. Mol Aspects Med 40: 1-116, 2014.
2. Tracey KJ: The inflammatory reflex. Nature 420: 853-859, 2002.
3. Pavlov VA, Wang H, Czura CJ, Friedman SG and Tracey KJ: The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 9: 125-134, 2003.
4. Silman NJ: Rapid diagnosis of sepsis using biomarker signatures. Crit Care 17: 1020, 2013.
5. Lyle NH, Pena OM, Boyd JH and Hancock R: Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies. Ann NY Acad Sci 1323: 101-114, 2014.
6. Xu L, Bao H, Si Y and Wang X: Effects of dexmedetomidine on early and late cytokines during polymicrobial sepsis in mice. Inflamm Res 62: 507-514, 2013.
7. Charoensup J, Sermswan RW, Paeyao A, Promakhejohn S, Punasee S, Chularari C, Krabkraikaew S, Lertanekawattana S and Wongratanacheewin S: High HMGB1 level is associated with poor outcome of septicemic melioidosis. Int J Infect Dis 28: 111-116, 2014.
8. Guo ZS, Liu ZQ, Bartlett DL, Tang DL and Lotze MT: Life after death: targeting high mobility group box 1 in emergent cancer therapies. Am J Cancer Res 3: 1-20, 2013.
9. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, et al: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221, 2004.
10. O'Connell RM, Rao DS and Baltimore D: microRNA regulation of inflammatory responses. Annu Rev Immunol 30: 295-312, 2012.
11. Moon HG, Yang J, Zheng Y and Jin Y: miR15a/16 regulates macrophage phagocytosis after bacterial infection. J Immunol 193: 4558-4567, 2014.
12. Chatterjee V, Beard RS Jr, Reynolds JJ, Haines R, Guo M, Rubin M, Guido J, Wu MH and Yuan SY: MicroRNA-147b regulates vascular endothelial barrier function by targeting ADAM15 expression. PLoS One 9: e110286, 2014.
13. Wang HJ, Deng J, Wang JY, Zhang PJ, Xin Z, Xiao K, Feng D, Jia YH, Liu YN and Xie LX: Serum miR122 levels are related to coagulation disorders in sepsis patients. Clin Chem Lab Med 52: 927-933, 2014.
14. Tacke F, Roderburg C, Benz F, Cardenas DV, Luedde M, Hippe HJ, Frey N, Vucur M, Gautheron J, Koch A, et al: Levels of circulating miR133a are elevated in sepsis and predict mortality in critically ill patients. Crit Care Med 42: 1096-1104, 2014.
15. Pavlov VA and Tracey KJ: Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans 34: 1037-1040, 2006.
16. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, et al: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388, 2003.
17. Sun Y, Li Q, Gui H, Xu DP, Yang YL, Su DF and Liu X: MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Res 23: 1270-1283, 2013.
18. Musumeci D, Roviello GN and Montesarchio D: An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1 related pathologies. Pharmacol Ther 141: 347-357, 2014.
19. Jia SZ, Yang Y, Lang J, Sun P and Leng J: Plasma miR17-5p, miR20a and miR22 are down-regulated in women with endometriosis. Hum Reprod 28: 322-330, 2013.
20. Cheng Z, Li-Sha G, Jing-Lin Z, Wen-Wu Z, Xue-Si C, Xing Xing C and Yue-Chun L: Protective role of the cholinergic anti-inflammatory pathway in a mouse model of viral myocarditis. PLoS One 9: e112719, 2014.
21. Koopman FA, Schuurman PR, Vervoordeldonk MJ and Tak PP: Vagus nerve stimulation: a new bioelectronics approach to treat rheumatoid arthritis? Best Pract Res Clin Rheumatol 28: 625-635, 2014.
22. Sitapara RA, Antoine DJ, Sharma L, Patel VS, Ashby CR Jr, Gorasiya S, Yang H, Zur M and Mantell LL: The 7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med 20: 238-247, 2014.
23. Cai B, Chen F, Ji Y, Kiss L, de Jonge WJ, Conejero-Goldberg C, Szabo C, Deitch EA and Ulloa L: Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation. J Cell Mol Med 13 (9B): 3774-3785, 2009.
24. Kox M, Pompe JC, Peters E, Vaneker M, van der Laak JW, van der Hoeven JG, Scheffer GJ, Hoedemaekers CW and Pickkers P: 7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-production and lung injury. Br J Anaesth 107: 559-566, 2011.
25. Pavlov VA, Ochani M, Yang LH, Gallowitsch-Puerta M, Ochani K, Lin X, Levi J, Parrish WR, Rosas-Ballina M, Czura CJ, et al: Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med 35: 1139-1144, 2007.
26. Zhang P, Wang L, Rodriguez-Aguayo C, Yuan Y, Debeb BG, Chen D, Sun Y, You MJ, Liu Y, Dean DC, et al: miR205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat Commun 5: 5671, 2014.
27. Lin D, Halilovic A, Yue P, Bellner L, Wang K, Wang L and Zhang C: Inhibition of miR205 impairs the wound-healing process in human corneal epithelial cells by targeting KIR4. 1 (KCNJ10). Invest Ophthalmol Vis Sci 54: 6167-6178, 2013.
28. Orang AV, Safaralizadeh R, Hosseinpour Feizi MA and Somi MH: Diagnostic and prognostic value of miR205 in colorectal cancer. Asian Pac J Cancer Prev 15: 4033-4037, 2014.
29. Qiao W, Chen L and Zhang M: MicroRNA-205 regulates the calcification and osteoblastic differentiation of vascular smooth muscle cells. Cell Physiol Biochem 33: 1945-1953, 2014.